- Issue of Warrants to IPF Funding Update
- Faron´s Annual Report 2023
- Additional Positive Data from Phase 1 of BEXMAB
- Faron to Host BEXMAB Webcast
- Notice of Annual General Meeting 2024
- Financial Statement January 1 to December 31 2023
- Binding commitments for convertible loans
- Replacement - Update to 2024 Financial Calendar
- Update to Faron’s Financial Calendar for 2024
- Continued Negotiations Regarding Events of Default
More ▼
Key statistics
On Thursday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 137.50, 14.58% above the 52 week low of 120.00 set on Mar 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 140.00 |
---|---|
High | 133.00 |
Low | 133.00 |
Bid | 130.00 |
Offer | 160.00 |
Previous close | 140.00 |
Average volume | 58.62k |
---|---|
Shares outstanding | 68.81m |
Free float | 40.03m |
P/E (TTM) | -- |
Market cap | 94.61m GBP |
EPS (TTM) | -0.4085 GBP |
Data delayed at least 20 minutes, as of Mar 28 2024 14:16 BST.
More ▼